Eli Lilly Gemzar

Related by string. * eli . Elis . ELI . ELIS . Elier : Eli Manning threw . quarterback Eli Manning . billionaires Eli Broad . Eli Roth Hostel . drugmaker Eli Lilly / LILLY . Lillys . lilly : starter Ted Lilly . Drugmaker Eli Lilly . INDIANAPOLIS Eli Lilly . Pfizer Eli Lilly . Eli Lilly LLY / GEMZAR : gemcitabine Gemzar ® . gemcitabine Gemzar R . Gemzar gemcitabine . gemcitabine Gemzar * *

Related by context. Frequent words. (Click for all words.) 71 Gemzar ® 69 Doxil 68 Camptosar 68 Fludara 67 Taxotere ® 67 Erlotinib 67 Herceptin trastuzumab 67 goserelin 66 Gemcitabine 66 Oxaliplatin 66 Irinotecan 66 Amrubicin 66 pertuzumab 66 metastatic hormone refractory 65 Hycamtin 65 temsirolimus 65 Targretin 65 mTOR inhibitor 65 mycophenolate mofetil 65 Treanda 64 ARIMIDEX 64 Zolinza 64 Rebif ® 64 Casodex 64 Nolvadex 64 Nexavar ® 64 Leukine 64 Abraxane 64 chlorambucil 64 epirubicin 64 Jevtana 64 Bevacizumab 64 Combination therapy 63 fluorouracil 63 Emend 63 PegIntron 63 Torisel 63 Avastin bevacizumab 63 Taxotere R 63 Arixtra 63 IRESSA 63 Carboplatin 63 Sorafenib 63 decitabine 63 Advexin 63 luteinizing hormone releasing 63 nilotinib 63 DAVANAT 62 dacarbazine 62 VIDAZA 62 Lenalidomide 62 androgen independent 62 Anastrozole 62 interferon alfa 62 Aromasin 62 Mylotarg 62 tocilizumab 62 vinorelbine 62 paclitaxel chemotherapy 62 Rebetol 62 Panitumumab 62 DOXIL 62 angiogenesis inhibitor 62 CoFactor 62 BAY #-# 62 Eloxatin 62 irbesartan 61 TREANDA 61 Cladribine 61 Cisplatin 61 Lialda 61 axitinib 61 ONTAK 61 octreotide 61 Navelbine 61 Docetaxel 61 Sandostatin LAR 61 Gemzar 61 Everolimus 61 active comparator 61 Trastuzumab 61 Stelara 61 relapsed refractory multiple myeloma 61 chemoradiotherapy 61 azacitidine 61 PARP inhibitor 61 Eloxatin R 61 refractory multiple myeloma 61 LY# [003] 60 mRCC 60 oral anticoagulant 60 epoetin alfa 60 tyrosine kinase inhibitor 60 metastatic renal cell carcinoma 60 peginterferon alfa 2b 60 plus prednisone 60 cabazitaxel 60 etoposide 60 FOLFIRI 60 Aldara 60 gastrointestinal stromal tumors

Back to home page